Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert


Search Title by author or title

Unilateral iris-claw intraocular lens implantation for aphakia: a paired-eye study

Poster Details

First Author: P. Verdaguer SPAIN

Co Author(s):    M. Morral   D. Elies   O. Gris   F. Manero   J. Guell        

Abstract Details


To perform a paired-eye comparison of secondary iris-claw intraocular lens (IOL) implantation for aphakia.


Instituto de Microcirurgia Ocular (IMO), Barcelona, Spain.


Retrospective, comparative, non-randomized interventional case seriesof aphakic eyes, which underwent secondary iris-claw Artisan IOL (Ophtec BV) implantation for aphakia in one eye and no surgery (Group 1) or cataract surgery (Group 2) in the fellow eye. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), spherical equivalent (SE), central endothelial cell count (cECC), and complications were evaluated before surgery, and at yearly intervals up to 5 years.


Thirty aphakic eyes implanted with Artisan and the fellow eyes as controls. In group 1, postoperative logMAR UDVA and CDVA was significantly higher in the Artisan-implanted eyes at all follow-up points (p≤0.05). In Group 2, no differences were found in postoperative UDVA and postoperative CDVA throughout the follow-up (p≥0.05). No statistically significant differences were found in postoperative SE between the Artisan-implanted eyes and the unoperated eyes or the eyes that underwent cataract surgery (p≥0.05). In Group 1, cECC was significantly lower in the Artisan-implanted eyes throughout the follow-up (p≤0.05). In group 2, cECC was not significantly lower in the Artisan-implanted eyes (p≥0.05).


Secondary iris-claw IOL implantation in aphakic eyes without capsular support is an effective and safe procedure. However, close monitoring of the corneal endothelium is mandatory.

Financial Disclosure:


Back to Poster listing